相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid and Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Paige E. Miller et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
Ryo Nishio et al.
ATHEROSCLEROSIS (2014)
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa for Lowering Very high triglyceridEs (EVOLVE) trial
John J. P. Kastelein et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1-executive summary
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A Retrospective Case Series of the Lipid Effects of Switching From Omega-3 Fatty Acid Ethyl Esters to Icosapent Ethyl in Hyperlipidemic Patients
Richard S. Castaldo
POSTGRADUATE MEDICINE (2014)
Potential Benefits of Icosapent Ethyl on the Lipid Profile: Case Studies
Daniel E. Hilleman et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2014)
Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Update on marine omega-3 fatty acids: Management of dyslipidemia and current omega-3 treatment options
Howard Weintraub
ATHEROSCLEROSIS (2013)
A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)
Kevin C. Maki et al.
CLINICAL THERAPEUTICS (2013)
n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Maria Carla Roncaglioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor
Takayuki Ishida et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2013)
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study
Elliot Offman et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2013)
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review
Javier Delgado-Lista et al.
BRITISH JOURNAL OF NUTRITION (2012)
Dietary sources of omega 3 fatty acids: public health risks and benefits
J. A. Tur et al.
BRITISH JOURNAL OF NUTRITION (2012)
Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis
Susanna C. Larsson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)
Fish Oil and Postoperative Atrial Fibrillation The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) Randomized Trial
Dariush Mozaffarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Lars Berglund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study
Michael H. Davidson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other Lipids: A review
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Jackie Bosch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
Melissa Y. Wei et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease
Hiroshige Itakura et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2011)
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Heribert Schunkert et al.
NATURE GENETICS (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Long Chain Omega-3 Dietary Supplements: A Review of the National Library of Medicine Herbal Supplement Database
Atanaz Zargar et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2011)
30-Year Trends in Serum Lipids Among United States Adults: Results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006
Jerome D. Cohen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
Abbie L. Cawood et al.
ATHEROSCLEROSIS (2010)
Fish Oil for the Treatment of Cardiovascular Disease
Daniel Weitz et al.
CARDIOLOGY IN REVIEW (2010)
OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
Bernhard Rauch et al.
CIRCULATION (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults
Earl S. Ford et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
Yasushi Saito et al.
ATHEROSCLEROSIS (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
Michael H. Davidson et al.
CLINICAL THERAPEUTICS (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review
Ethan M. Balk et al.
ATHEROSCLEROSIS (2006)
Why do omega-3 fatty acids lower serum triglycerides?
William S. Harris et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored
PC Calder
CLINICAL SCIENCE (2004)
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial
F Thies et al.
LANCET (2003)
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
PM Kris-Etherton et al.
CIRCULATION (2002)
分享论文
